#144: Dispensary by IYHP (08/12)

• Carlyle Group sold a ₹636 crore stake in Indegene, reducing its holding to 10.22%.

• GIC is set to acquire a larger stake in Asia Healthcare Holdings from majority owner TPG, ahead of a potential IPO.

• Kotak Pre-IPO Fund plans to invest in diagnostic chain Neuberg.

• KKR is nearing the acquisition of cancer treatment chain HCG.

• Ontario Teachers' Pension Plan is likely to sell Sahyadri Hospitals.

1. Nuvig Therapeutics raised $161M in Series B funding to advance its immunology-based therapies.

2. Cleerly raised $106M to expand its AI-based cardiac imaging platform.

3. Maze Therapeutics raised $115M in Series D financing to accelerate its genetic medicine programs.

1. Antag Therapeutics raised €80M in Series A financing to develop metabolic and cardiovascular disease therapies.

2. Qi Biodesign completed $75M in funding to scale its AI-driven drug discovery.

3. Soda Health raised $50M in Series B funding to improve social determinants of health solutions.

4. Midiagnostics raised €30M in Series D funding to enhance its point-of-care diagnostics platform.

5. Sollis Health raised $33M in Series B funding to expand its concierge healthcare services.

6. Ossio raised $27.6M in Equity Funding to increase patient access to metal-free surgical implants

7. ModifyHealth raised $13.5M in Series C funding to grow its food-as-medicine programs.

8. Serina Therapeutics raised $10M in financing for its polymer-based drug delivery technology.

9. Nua Surgical raised €6.5M in Series A financing to develop women’s health devices.

10. Orakl Oncology raised €11M in seed funding for its oncology drug discovery platform.

1. Refoxy Pharmaceuticals raised €9.1M in seed extension funding to advance its early-stage therapeutics.

2. StretchDollar raised $6M to develop its financial literacy platform.

3. Trio Pharmaceuticals completed $3.1M in funding to expand its oncology programs.

4. 52North raised $4.72M to grow its wearable health technology.

5. Newcells raised £1.2M in additional funding to enhance its drug testing models.

1. Care.io raised strategic seed funding to launch its patient engagement solutions.

As always, we're here to keep you informed and up to speed with the latest in healthcare. With close to 1,500 subscribers already in the know, you're in great company. If you haven't yet, feel free to hit subscribe and never miss an update.

That’s it, until next week.

Rahul and Aditya